Ecolab Faces 'Less Potential for Outsized Stock Gain' Amid 'Balanced' Outlook, UBS Says

MT Newswires Live11-05

Ecolab (ECL) faces "less potential for outsized stock gains" with prospects for risks and reward "balanced at current levels," UBS Securities said Monday in a report.

After 22% earnings per share growth annually in the past two years, adjusted EPS is expected to return to a "normal" range of 12% to 15%, the report said.

UBS downgraded Ecolab's stock to hold from buy with a 12-month price target of $276.

Following Q3 results, UBS trimmed 2025-26 EPS forecasts about 4% with margins and beats below expectations and pricing and costs benefits "now largely done," according to the report.

Institutional segment organic growth is expected to moderate from the current high single-digit percentage level, countered by improving growth in industrial and health care and life sciences, UBS said.

Ecolab shares fell 0.7% in recent trading Monday.

Price: 242.79, Change: -1.79, Percent Change: -0.73

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment